InnoCan Pharma Corporation (CSE:INNO)
Canada · Delayed Price · Currency is CAD 19.10
-0.21 (-1.09%)
Oct 10, 2025, 11:58 AM EDT
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 116.58 million as of October 10, 2025. Its market cap has increased by 70.03% in one year.
Market Cap
116.58M
Enterprise Value
111.98M
Revenue
39.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.10
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 116.58M, an increase of 10,872.24%. That is a compound annual growth rate of 117.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 118.87M | 97.28% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | 62.49M | 171.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.45B |
| Green Thumb Industries | 2.93B |
| Trulieve Cannabis | 2.37B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.74B |
| WELL Health Technologies | 1.42B |
| Cronos Group | 1.39B |
| Extendicare | 1.24B |